Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, Palmieri C, Chap LI, Richards P, Gradishar W, Sardesai S, Melear J, O'Shaughnessy J, Ward P, Chalasani P, Arkenau T, Baird RD, Jeselsohn R, Ali S, Clack G, Bahl A, McIntosh S, Krebs MG.
Coombes RC, et al. Among authors: kenny l.
Nat Commun. 2025 Mar 6;16(1):2242. doi: 10.1038/s41467-025-57535-w.
Nat Commun. 2025.
PMID: 40050276
Free PMC article.
No abstract available.